A share price of Novartis AG ADR [NVS] is currently trading at $94.41, up 0.95%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NVS shares have lost -1.12% over the last week, with a monthly amount drifted -3.79%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on February 23, 2024, when BMO Capital Markets initiated its Market Perform rating and assigned the stock a price target of $114. Previously, Morgan Stanley started tracking the stock with Equal-Weight rating on January 23, 2024, and set its price target to $114. HSBC Securities downgraded its rating to a Hold. Morgan Stanley upgraded its rating to a Equal-Weight. In a note dated April 26, 2023, Deutsche Bank upgraded an Buy rating on this stock.
Novartis AG ADR experienced fluctuations in its stock price throughout the past year between $88.86 and $108.78. Novartis AG ADR [NYSE: NVS] shares were valued at $94.41 at the most recent close of the market.
Analyzing the NVS fundamentals
Trailing Twelve Months sales for Novartis AG ADR [NYSE:NVS] were 49.78B which represents -9.98% decline. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.29%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.31 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.56.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 94.03 points at the first support level, and at 93.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 94.88, and for the 2nd resistance point, it is at 95.35.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Novartis AG ADR [NYSE:NVS] is 1.16. In addition, the Quick Ratio stands at 0.93 and the Cash Ratio stands at 0.51. Considering the valuation of this stock, the price to sales ratio is 3.71, the price to book ratio is 4.14 and price to earnings (TTM) ratio is 13.22.
